Glucosylceramide synthase and glycosphingolipid synthesis

By Ichikawa S.   Hirabayashi Y.  

Trends in Cell Biology, Vol. 8, Iss. 5, 1998-05 ,pp. : 198-202

Elsevier

Access to resources Recommend Favorite

Integrin beta3 cDNA Transfection into a Highly Metastatic alphavbeta3-Negative Human Melanoma Cell Line Inhibits Invasion and Experimental Metastasis

By Danen E.H.J.   van Kraats A.A.   Cornelissen I.M.H.A.   Ruiter D.J.   van Muijen G.N.P.  

Biochemical and Biophysical Research Communications, Vol. 226, Iss. 1, 1996-09 ,pp. : 75-81

Elsevier

Access to resources Recommend Favorite

Differential Chemosensitizing Effect of Two Glucosylceramide Synthase Inhibitors in Hepatoma Cells

By di Bartolomeo S.   Spinedi A.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 1, 2001-10 ,pp. : 269-274

Elsevier

Access to resources Recommend Favorite

The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat

By Treiber A.   Morand O.   Clozel M.  

Xenobiotica, Vol. 37, Iss. 3, 2007-03 ,pp. : 298-314

Informa Healthcare

Access to resources Recommend Favorite

A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A₂ with ceramide transacylase activity

By Shayman James   Abe Akira   Hiraoka Miki  

Glycoconjugate Journal, Vol. 20, Iss. 1, 2003-02 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite